# Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer

> **NCT06583655** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 205 (estimated)

## Conditions studied

- Breast Cancer Invasive

## Interventions

- **RADIATION:** SLND(clinical low risk)
- **RADIATION:** SLND(clinical high risk, genomic low risk)
- **RADIATION:** SLND alone ,clinical high risk and genomic high risk group
- **RADIATION:** Sentinel Lymph Node Dissection(SLND) + axillary lymph node dissection(ALND)

## Key facts

- **NCT ID:** NCT06583655
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 205 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06583655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06583655, "Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06583655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*